<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-161160" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>UK Screening and Surveillance For Bowel Cancers</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shekleton</surname>
            <given-names>Florence E.</given-names>
          </name>
          <aff>Newcastle University Medical School</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Okocha</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>University of Bristol</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Florence Shekleton declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Okocha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-161160.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Colorectal cancer is the fourth-deadliest cancer in the world and causes approximately 900,000 deaths annually.<xref ref-type="bibr" rid="article-161160.r1">[1]</xref>&#x000a0;Early detection of colorectal cancer through effective screening programmes has the potential to reduce the incidence and mortality associated with the disease. Within the United Kingdom (UK) National Health Service (NHS), evidence-based screening and surveillance strategies aim to reduce morbidity and mortality secondary to colorectal cancer in asymptomatic and high-risk patients.&#x000a0;</p>
        <p>
<bold>Screening&#x000a0;</bold>
</p>
        <p>Cancer screening is designed to detect the presence of cancer or precancerous conditions in individuals who do not have any symptoms of the disease. The primary goal of cancer screening is to identify cancer at an early and more treatable stage when interventions are likely to be more successful.<xref ref-type="bibr" rid="article-161160.r2">[2]</xref>&#x000a0;Bowel cancer screening is&#x000a0;operated through the NHS&#x000a0;along with breast and cervical cancer screening programmes.&#x000a0;</p>
        <p>
<bold>Disease Surveillance&#x000a0;</bold>
</p>
        <p>The primary aim of disease surveillance is to reduce colorectal cancer incidence in patients at higher risk of disease&#x000a0;by identifying and resecting de novo and missed polyps, thereby preventing their progression to cancer. The secondary aim of disease surveillance is to reduce mortality from bowel cancer.&#x000a0;</p>
        <p>Surveillance is offered to 2&#x000a0;groups of patients in the UK: those with a high risk of hereditary colorectal cancer and those with previous personal history of colorectal cancer.&#x000a0;Heritable factors account for approximately 35% of colorectal cancer risk in the UK; almost 30% of the UK population have a family history of colorectal cancer.<xref ref-type="bibr" rid="article-161160.r3">[3]</xref>&#x000a0;Between 50% and 60% of patients presenting with curative colorectal cancer disease will relapse with metastatic disease.<xref ref-type="bibr" rid="article-161160.r4">[4]</xref><xref ref-type="bibr" rid="article-161160.r5">[5]</xref><xref ref-type="bibr" rid="article-161160.r6">[6]</xref>&#x000a0;Surveillance&#x000a0;is a key component of risk reduction interventions.</p>
      </sec>
      <sec id="article-161160.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Epidemiology</bold>
</p>
        <p>Approximately 43,000 people are diagnosed with bowel cancer annually in the UK. The incidence of colorectal cancer increases&#x000a0;with age; most patients newly diagnosed with colorectal cancer are aged 60 years or older. Colorectal cancer survival rates vary with age at diagnosis, gender, ethnicity, and socioeconomic status but are most heavily dictated by stage at diagnosis. The 5-year survival rate for the earliest stage (Dukes A) of colorectal cancer is 85%, whereas for the latest stage (Dukes D), it is 10%. Despite the efforts of the NHS, in England, there is a reported 7% to 10% difference in the 1-year relative survival rates for colorectal cancer between the most affluent and deprived populations.<xref ref-type="bibr" rid="article-161160.r7">[7]</xref></p>
        <p>
<bold>Aetiology</bold>
</p>
        <p>Genetic and environmental factors play a role in the aetiology of colorectal cancer. Understanding the diversity of factors is essential for tailoring effective screening and surveillance strategies for the general and at-risk populations. Approximately 20% of colorectal cancers are linked to genetic risk factors. The risk of an individual developing colorectal cancer doubles in those with a first-degree family history and triples when that family member is younger than 50 years at the time of diagnosis.<xref ref-type="bibr" rid="article-161160.r8">[8]</xref>&#x000a0;Hereditary cancer syndromes such as hereditary nonpolyposis cancer syndrome or familial adenomatous polyposis account for 5% to 10% of all colorectal cancer diagnoses.<xref ref-type="bibr" rid="article-161160.r9">[9]</xref>&#x000a0;Approximately 1% of all colorectal cancers&#x000a0;are due to chronic inflammation due to inflammatory bowel disease.<xref ref-type="bibr" rid="article-161160.r10">[10]</xref></p>
        <p>Environmental factors significantly contribute to the pathogenesis of colorectal cancer. Consuming a diet high in red and processed meats that contain potentially carcinogenic substances has been linked to an increased risk of developing colorectal cancer.<xref ref-type="bibr" rid="article-161160.r11">[11]</xref>&#x000a0;Conversely, consuming a diet rich in fruits, vegetables, and fibre appears to offer protective effects against colorectal cancer. Obesity, a chronic inflammatory state characterized by insulin resistance, has also been identified as a risk factor for colorectal cancer; physical inactivity contributes to this risk.<xref ref-type="bibr" rid="article-161160.r12">[12]</xref><xref ref-type="bibr" rid="article-161160.r13">[13]</xref>&#x000a0;Individuals&#x000a0;with type 2 diabetes are also at an increased risk of colorectal cancer, likely secondary to the same pathogenic mechanisms.<xref ref-type="bibr" rid="article-161160.r14">[14]</xref>&#x000a0;Tobacco is a known carcinogen and has adverse effects on colorectal health, as does heavy alcohol consumption.<xref ref-type="bibr" rid="article-161160.r15">[15]</xref><xref ref-type="bibr" rid="article-161160.r16">[16]</xref>&#x000a0;</p>
        <p>
<bold>Pathogenesis</bold>
</p>
        <p>Colorectal&#x000a0;cancer can affect the colon and rectum. Rectal cancer accounts for 49.66% of colorectal cancers, colon cancer accounts for 49.09%, and&#x000a0;cancers found in both sites account for 1.25%.<xref ref-type="bibr" rid="article-161160.r17">[17]</xref></p>
        <p>The adenoma-carcinoma sequence is a well-documented pathogenic framework for colorectal cancer. Initiated by the development of benign adenomatous polyps within the colonic mucosa, this sequence unfolds through the accumulation of genetic and molecular alterations.<xref ref-type="bibr" rid="article-161160.r18">[18]</xref>&#x000a0;These alterations drive the transformation to high-grade dysplastic adenomatous disease. The inactivation of tumour suppressor genes and activation of oncogenes are pivotal to this transformative process.<xref ref-type="bibr" rid="article-161160.r19">[19]</xref>&#x000a0;A subset of these dysplastic adenomas will acquire the hallmarks of cancer and become malignant. The adenoma-carcinoma sequence guides early detection efforts and preventive interventions through colonoscopic surveillance and the resection of precursor lesions.<xref ref-type="bibr" rid="article-161160.r20">[20]</xref></p>
      </sec>
      <sec id="article-161160.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>
<bold>Screening Guidelines</bold>
</p>
        <p>Each of the 4 nations in the UK has&#x000a0;a slightly different screening programme.&#x000a0;Screening is recommended for different age groups within each nation.&#x000a0;The recommended age-based screening brackets are:</p>
        <list list-type="bullet">
          <list-item>
            <p>England: between 60 and 74 years of age; currently expanding to&#x000a0;include individuals between 50 and 59 years of age</p>
          </list-item>
          <list-item>
            <p>Northern Ireland: between 60 and 74 years of age</p>
          </list-item>
          <list-item>
            <p>Scotland: between 50 and 74 years of age</p>
          </list-item>
          <list-item>
            <p>Wales: between 51 and 74 years of age.</p>
          </list-item>
        </list>
        <p>Colorectal cancer screening previously&#x000a0;employed faecal occult blood tests (FOBT) and shifted to faecal immunochemical tests (FIT) in 2019. FIT utilizes antibodies specific to human haemoglobin (Hb). The results of FIT are&#x000a0;not negatively influenced by the presence of nonhuman blood in stools, such as that ingested through diet; this reduces the chance of falsely positive results. The FIT has a sensitivity of 79% and a specificity of 94%, both higher than FOBT.<xref ref-type="bibr" rid="article-161160.r21">[21]</xref><xref ref-type="bibr" rid="article-161160.r22">[22]</xref>&#x000a0;Patient uptake rates for FITs are rising; the most recent data&#x000a0;reveals 69.6% uptake in England, 62.1% in Northern Ireland, 66.7% in Scotland, and 67.1% in Wales.&#x000a0;</p>
        <p>The results of FIT are reported in micrograms of haemoglobin&#x000a0;per gram of faeces (&#x000b5;g/g), and the decision threshold is 120 &#x000b5;g/g. Patients whose results fall above this value are referred to a specialist screening practitioner clinic appointment to discuss their results and further investigations, which may include a colonoscopy. Patients with a FIT result below the threshold are offered another FIT in 2 years.&#x000a0;</p>
        <p>If a patient presents to their&#x000a0;primary care practitioner with symptoms concerning for colorectal cancer, current guidelines recommend performing a FIT. If the result exceeds 10 &#x000b5;g/g, the patient receives an urgent referral into the 2-week wait pathway. If the FIT result does not meet this threshold, but there are ongoing clinical concerns with persistent symptoms, safety net advice is recommended, with further referral as deemed necessary.<xref ref-type="bibr" rid="article-161160.r23">[23]</xref>&#x000a0;Colonoscopy is generally performed through the 2-week wait pathway, designed to ensure that patients with symptoms suggestive of colorectal cancer receive a prompt and expedited referral to a specialist within 2 weeks.</p>
        <p>
<bold>Hereditary Colorectal Cancer Guidelines&#x000a0;</bold>
</p>
        <p>Detailed surveillance guidelines exist for average-, moderate-, and high-risk hereditary colorectal cancer surveillance.<xref ref-type="bibr" rid="article-161160.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Average-risk patients are those with no family history of colorectal cancer or who do not meet moderate- or high-risk criteria; these patients should&#x000a0;adhere to the routine national screening programme.</p>
          </list-item>
          <list-item>
            <p>Moderate-risk patients are those with&#x000a0;one affected first-degree relative diagnosed&#x000a0;with colorectal cancer before the age of 50&#x000a0;or 2 affected first-degree relatives diagnosed at any age. Moderate-risk patients should undergo colonoscopy at 55 years of age. If this colonoscopy reveals no abnormalities, the patient may return to the routine national screening programme. If this colonoscopy reveals polyps, the patient should enter the post-polypectomy surveillance guideline programme.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>High-risk patients are those with a minimum of 3 first-degree relatives with colorectal cancer diagnosed at any age; affected relatives must span a minimum of 2 generations.&#x000a0;High-risk patients should undergo colonoscopy every 5 years beginning at 40 years of age.&#x000a0;</p>
          </list-item>
        </list>
        <p>Patients suspected of having an underlying genetic disorder, such as familial adenomatous polyposis or hereditary nonpolyposis colon cancer, sometimes referred to as Lynch syndrome, should receive a referral for genetic assessment. Separate in-depth guidelines for these and other genetic disorders exist&#x000a0;and are not discussed in this activity.</p>
        <p>
<bold>Surveillance Following Surgical Management With Curative Intent</bold>
</p>
        <p>The National Institute for Health and Care Excellence in the UK (NICE UK) provides recommendations for surveillance following surgical management with curative intent for colorectal cancer. These surveillance recommendations comprise serum carcinoembryonic antigen (CEA) testing every 6 months for 3 years, computed tomography (CT) scans at 1&#x000a0;and 2 years, and colonoscopy at 1 and 3 years.&#x000a0;</p>
        <p><bold>Carcinoembryonic antigen:&#x000a0;</bold>Carcinoembryonic antigen (CEA) is the most commonly used tumour marker in colorectal cancer surveillance. Serum CEA is elevated in as many as 75% of patients with recurrent colorectal cancer, and CEA is often the first indicator of recurrence.<xref ref-type="bibr" rid="article-161160.r24">[24]</xref>&#x000a0;However, the sensitivity and specificity of CEA as a marker of recurrence are as low as 44% and 42%, respectively; many benign diseases and most adenocarcinoma subtypes increase serum CEA.<xref ref-type="bibr" rid="article-161160.r25">[25]</xref>&#x000a0;Serum CEA is not recommended as a screening or diagnostic test&#x000a0;for colorectal cancer. Healthy individuals who do not smoke tobacco typically have a serum CEA of &#x02264; 3.0 &#x000b5;g/L; tobacco use naturally increases circulating serum CEA, and the upper limit of normal for serum CEA in individuals who smoke is typically 5 &#x000b5;g/L. In patients undergoing surgical intervention for colorectal cancer, elevated serum CEA levels in the pre- or postoperative period are associated with worse outcomes.<xref ref-type="bibr" rid="article-161160.r26">[26]</xref></p>
        <p><bold>Computed tomography: </bold>Imaging surveillance regimens vary among NHS trusts. However, CT scans are generally performed at 1-year and 2-year intervals following surgery for colorectal cancer. CT has&#x000a0;demonstrated 100% sensitivity and 95.7% specificity in detecting&#x000a0;colorectal cancer. CT scans are well-accepted by patients, low-risk, and quick to perform.<xref ref-type="bibr" rid="article-161160.r27">[27]</xref></p>
        <p><bold>Colonoscopy: </bold>Guidelines published in 2020 by the<bold>&#x000a0;</bold>British Society of Gastroenterology, Association of Coloproctology of Great Britain and Ireland, and Public Health England delineate pathways for surveillance following polypectomy and resection of colorectal cancer.<xref ref-type="bibr" rid="article-161160.r28">[28]</xref>&#x000a0;Per these guidelines, patients diagnosed with colorectal cancer should undergo colonoscopy 1 year following cancer resection.</p>
        <p>Patients who have undergone an en-bloc resection of a large, histological R0 nonpedunculated colorectal polyps should undergo a one-time surveillance colonoscopy 3 years following polypectomy. However, patients who have undergone a non&#x02013;en-bloc excision of a large, histological R0 nonpedunculated colorectal polyp should undergo a site check within 2 to 6 months following polypectomy and another site check at 12 months following polypectomy.</p>
        <p>Patients with high-risk colonoscopic findings should undergo another colonoscopy in 3 years. High-risk findings are defined as:</p>
        <list list-type="bullet">
          <list-item>
            <p>the presence of 5 or more premalignant polyps</p>
          </list-item>
          <list-item>
            <p>the presence of 2 or more premalignant colorectal polyps where&#x000a0;at least 1 polyp is considered advanced.</p>
          </list-item>
        </list>
        <p>Advanced polyps are defined as:</p>
        <list list-type="bullet">
          <list-item>
            <p>an&#x000a0;adenomatous polyp measuring 10 or more millimetres in size or containing high-grade dysplasia</p>
          </list-item>
          <list-item>
            <p>a serrated polyp measuring&#x000a0;10 or more millimetres&#x000a0;in size or containing any grade of dysplasia.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-161160.s4" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Contraindications to Screening and Surveillance for Colorectal Cancer</bold>
</p>
        <p>Despite FIT testing being generally risk-free, patients decline screening invitations. Efforts to increase patient uptake and reduce inequalities throughout the UK are ongoing. Individuals have the right to refuse screening or surveillance for any reason. However, screening and surveillance for colorectal cancer may not be advisable&#x000a0;in specific circumstances. The circumstances include but are not limited to:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients 75 years or older, for whom the procedural risks or burden may not outweigh the benefits of early detection and intervention.<xref ref-type="bibr" rid="article-161160.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Patients of any age with a life expectancy of less than 10 years, for whom the procedural risks or burden may not outweigh the benefits of early detection and intervention.<xref ref-type="bibr" rid="article-161160.r28">[28]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Patients with significant medical comorbidities, such as advanced cardiovascular disease, may be unsuitable candidates for colorectal cancer surveillance. The complication rate for colonoscopy is 4 to 8 for every 10,000 procedures performed and includes bleeding, bowel perforation, pain, and adverse effects of anaesthesia.<xref ref-type="bibr" rid="article-161160.r29">[29]</xref>&#x000a0;The incidence of these complications increases significantly in older and medically frail patients, who are also disproportionally affected by the risks of electrolyte disturbance and hypoglycaemia secondary to bowel preparation regimens.<xref ref-type="bibr" rid="article-161160.r30">[30]</xref><xref ref-type="bibr" rid="article-161160.r31">[31]</xref><xref ref-type="bibr" rid="article-161160.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p>Inadequate bowel preparation can be a contraindication to colonoscopic surveillance.</p>
          </list-item>
          <list-item>
            <p>Patients experiencing postoperative complications following surgical resection of colorectal cancer, such as an anastomotic leak, may be unsuitable for colonoscopic surveillance until their clinical status improves.&#x000a0;</p>
          </list-item>
        </list>
        <p>Contraindications for using bowel cleansing agents include the use of lithium, acute intestinal or gastric ulceration, renal impairment, electrolyte imbalances, hypersensitivity to bowel cleansing agents, gastric retention, dysphagia, severe heart failure, reduced consciousness, an acute exacerbation of inflammatory bowel disease, and gastrointestinal obstruction, perforation or ileus.</p>
        <p>
<bold>Alternatives to Colonoscopy</bold>
</p>
        <p>Colonoscopy is considered the gold standard for colorectal cancer screening and surveillance due to its ability to provide direct visualisation of the colon and rectum. However, there are alternate screening and diagnostic methods, each with advantages and limitations. Commonly employed alternatives include sigmoidoscopy, virtual colonoscopy, barium enema, and capsule endoscopy.</p>
        <p>Sigmoidoscopy is less invasive than colonoscopy. While sigmoidoscopy may be employed for colorectal screening or surveillance, the procedure examines only the sigmoid colon and rectum; complete visualisation of the colon is not performed.<xref ref-type="bibr" rid="article-161160.r33">[33]</xref></p>
        <p>Virtual colonoscopy, also known as CT colonography, is a radiologic imaging technique that&#x000a0;uses CT images to create detailed images of the colon. Virtual colonoscopy is less invasive than traditional colonoscopy and does not require sedation. However, this procedure usually requires bowel preparation, and if abnormalities are detected, a follow-up colonoscopy is typically recommended for biopsy confirmation and treatment.<xref ref-type="bibr" rid="article-161160.r34">[34]</xref></p>
        <p>A barium enema is a radiologic procedure during which the colon is filled with barium contrast material. Barium enemas were historically the preferred screening modality for colorectal cancer but are infrequently performed for this purpose in current clinical practice due to the availability of other, more accurate screening methods.</p>
        <p>Capsule endoscopy utilises a small capsule&#x000a0;containing a camera that the patient swallows. The camera obtains still images as it passes through the alimentary tract. Capsule endoscopy is primarily used for examining the small intestine and is not a standard colorectal cancer screening or surveillance method.<xref ref-type="bibr" rid="article-161160.r35">[35]</xref></p>
      </sec>
      <sec id="article-161160.s5" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Multidisciplinary teams enhance colorectal cancer screening and surveillance by promoting collaboration among specialists, ensuring adherence to evidence-based guidelines, and providing personalised patient care. Multidisciplinary teams assess individual risk profiles, recommend appropriate screening strategies, and facilitate early diagnosis of colorectal disease through staging when abnormalities are detected. These teams develop tailored treatment plans, coordinate ongoing care, and address patient needs, including symptom management and psychosocial support. All team members play a vital role in educating patients and promoting informed decision-making, ultimately improving patient outcomes and the overall quality of colorectal cancer management.</p>
      </sec>
      <sec id="article-161160.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=161160&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=161160">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/161160/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=161160">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-161160.s7">
        <title>References</title>
        <ref id="article-161160.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dekker</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tanis</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Vleugels</surname>
                <given-names>JLA</given-names>
              </name>
              <name>
                <surname>Kasi</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Colorectal cancer.</article-title>
            <source>Lancet</source>
            <year>2019</year>
            <month>Oct</month>
            <day>19</day>
            <volume>394</volume>
            <issue>10207</issue>
            <fpage>1467</fpage>
            <page-range>1467-1480</page-range>
            <pub-id pub-id-type="pmid">31631858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neal</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Tharmanathan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>France</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Din</surname>
                <given-names>NU</given-names>
              </name>
              <name>
                <surname>Cotton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fallon-Ferguson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hendry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hendry</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Macleod</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Pickett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stuart</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>T&#x000f8;rring</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Emery</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.</article-title>
            <source>Br J Cancer</source>
            <year>2015</year>
            <month>Mar</month>
            <day>31</day>
            <volume>112 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S92</fpage>
            <page-range>S92-107</page-range>
            <pub-id pub-id-type="pmid">25734382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monahan</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Bradshaw</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dolwani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Desouza</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dunlop</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>East</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ilyas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lalloo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Latchford</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>HJW</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>J</given-names>
              </name>
              <collab>Hereditary CRC guidelines eDelphi consensus group</collab>
            </person-group>
            <article-title>Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).</article-title>
            <source>Gut</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>411</fpage>
            <page-range>411-444</page-range>
            <pub-id pub-id-type="pmid">31780574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Chun</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Yun</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shim</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival.</article-title>
            <source>Int J Colorectal Dis</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>699</fpage>
            <page-range>699-704</page-range>
            <pub-id pub-id-type="pmid">17109105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Cutsem</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nordlinger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>K&#x000f6;hne</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Pozzo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Poston</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ychou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rougier</surname>
                <given-names>P</given-names>
              </name>
              <collab>European Colorectal Metastases Treatment Group</collab>
            </person-group>
            <article-title>Towards a pan-European consensus on the treatment of patients with colorectal liver metastases.</article-title>
            <source>Eur J Cancer</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>42</volume>
            <issue>14</issue>
            <fpage>2212</fpage>
            <page-range>2212-21</page-range>
            <pub-id pub-id-type="pmid">16904315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yoo</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Lopez-Soler</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.</article-title>
            <source>Clin Colorectal Cancer</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-7</page-range>
            <pub-id pub-id-type="pmid">17026789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kajiwara Saito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quaresma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Benitez Majano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rachet</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Socioeconomic gaps over time in colorectal cancer survival in England: flexible parametric survival analysis.</article-title>
            <source>J Epidemiol Community Health</source>
            <year>2021</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>12</issue>
            <fpage>1155</fpage>
            <page-range>1155-1164</page-range>
            <pub-id pub-id-type="pmid">34049927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuipers</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Grady</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Seufferlein</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sung</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Boelens</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>van de Velde</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Colorectal cancer.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2015</year>
            <month>Nov</month>
            <day>05</day>
            <volume>1</volume>
            <fpage>15065</fpage>
            <pub-id pub-id-type="pmid">27189416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasen</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Tomlinson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Castells</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical management of hereditary colorectal cancer syndromes.</article-title>
            <source>Nat Rev Gastroenterol Hepatol</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>88</fpage>
            <page-range>88-97</page-range>
            <pub-id pub-id-type="pmid">25582351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jess</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rungoe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peyrin-Biroulet</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>639</fpage>
            <page-range>639-45</page-range>
            <pub-id pub-id-type="pmid">22289873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aune</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vieira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Greenwood</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Kampman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Norat</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies.</article-title>
            <source>PLoS One</source>
            <year>2011</year>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>e20456</fpage>
            <pub-id pub-id-type="pmid">21674008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gunter</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Leitzmann</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes.</article-title>
            <source>J Nutr Biochem</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>145</fpage>
            <page-range>145-56</page-range>
            <pub-id pub-id-type="pmid">16426829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Keegel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bull</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Heyworth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fritschi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis.</article-title>
            <source>J Natl Cancer Inst</source>
            <year>2012</year>
            <month>Oct</month>
            <day>17</day>
            <volume>104</volume>
            <issue>20</issue>
            <fpage>1548</fpage>
            <page-range>1548-61</page-range>
            <pub-id pub-id-type="pmid">22914790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Giovannucci</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Harlan</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Bergenstal</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Gapstur</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Habel</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Regensteiner</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Yee</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Diabetes and cancer: a consensus report.</article-title>
            <source>Diabetes Care</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>1674</fpage>
            <page-range>1674-85</page-range>
            <pub-id pub-id-type="pmid">20587728</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chang-Claude</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seiler</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Rickert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hoffmeister</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Protection from colorectal cancer after colonoscopy: a population-based, case-control study.</article-title>
            <source>Ann Intern Med</source>
            <year>2011</year>
            <month>Jan</month>
            <day>04</day>
            <volume>154</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-30</page-range>
            <pub-id pub-id-type="pmid">21200035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fedirko</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tramacere</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bagnardi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scotti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Islami</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Straif</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Romieu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>La Vecchia</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Boffetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jenab</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies.</article-title>
            <source>Ann Oncol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>9</issue>
            <fpage>1958</fpage>
            <page-range>1958-1972</page-range>
            <pub-id pub-id-type="pmid">21307158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and risk factors of colorectal cancer in China.</article-title>
            <source>Chin J Cancer Res</source>
            <year>2020</year>
            <month>Dec</month>
            <day>31</day>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>729</fpage>
            <page-range>729-741</page-range>
            <pub-id pub-id-type="pmid">33446996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vogelstein</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fearon</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Kern</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Preisinger</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Leppert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smits</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bos</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Genetic alterations during colorectal-tumor development.</article-title>
            <source>N Engl J Med</source>
            <year>1988</year>
            <month>Sep</month>
            <day>01</day>
            <volume>319</volume>
            <issue>9</issue>
            <fpage>525</fpage>
            <page-range>525-32</page-range>
            <pub-id pub-id-type="pmid">2841597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fearon</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Vogelstein</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>A genetic model for colorectal tumorigenesis.</article-title>
            <source>Cell</source>
            <year>1990</year>
            <month>Jun</month>
            <day>01</day>
            <volume>61</volume>
            <issue>5</issue>
            <fpage>759</fpage>
            <page-range>759-67</page-range>
            <pub-id pub-id-type="pmid">2188735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winawer</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Zauber</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Waye</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Schapiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bond</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Panish</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.</article-title>
            <source>N Engl J Med</source>
            <year>1993</year>
            <month>Dec</month>
            <day>30</day>
            <volume>329</volume>
            <issue>27</issue>
            <fpage>1977</fpage>
            <page-range>1977-81</page-range>
            <pub-id pub-id-type="pmid">8247072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stonestreet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chandrapalan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Woolley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Uthman</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Arasaradnam</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.</article-title>
            <source>Acta Gastroenterol Belg</source>
            <year>2019</year>
            <season>Apr-Jun</season>
            <volume>82</volume>
            <issue>2</issue>
            <fpage>291</fpage>
            <page-range>291-299</page-range>
            <pub-id pub-id-type="pmid">31314191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mousavinezhad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Majdzadeh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Akbari Sari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delavari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mohtasham</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test.</article-title>
            <source>Med J Islam Repub Iran</source>
            <year>2016</year>
            <volume>30</volume>
            <fpage>366</fpage>
            <pub-id pub-id-type="pmid">27493910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Monahan</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Abulafi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Banerjea</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nicholson</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Arasaradnam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Benton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Booth</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Burling</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carten</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>East</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kleijnen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Machesney</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pettman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pipe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Saker</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stephenson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG).</article-title>
            <source>Gut</source>
            <year>2022</year>
            <month>Jul</month>
            <day>12</day>
            <volume>71</volume>
            <issue>10</issue>
            <fpage>1939</fpage>
            <page-range>1939-62</page-range>
            <pub-id pub-id-type="pmid">35820780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyerhardt</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Follow-up strategies after curative resection of colorectal cancer.</article-title>
            <source>Semin Oncol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>349</fpage>
            <page-range>349-60</page-range>
            <pub-id pub-id-type="pmid">12870136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lauretta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montori</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guerrini</surname>
                <given-names>GP</given-names>
              </name>
            </person-group>
            <article-title>Surveillance strategies following curative resection and non-operative approach of rectal cancer: How and how long? Review of current recommendations.</article-title>
            <source>World J Gastrointest Surg</source>
            <year>2023</year>
            <month>Feb</month>
            <day>27</day>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-192</page-range>
            <pub-id pub-id-type="pmid">36896297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filiz</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Sucullu</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kurt</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Karakas</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Gulec</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Akin</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?</article-title>
            <source>Clinics (Sao Paulo)</source>
            <year>2009</year>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>287</fpage>
            <page-range>287-94</page-range>
            <pub-id pub-id-type="pmid">19488584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Colvin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lukram</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sohail</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Jehangir</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Babu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hinson</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The performance of routine computed tomography for the detection of colorectal cancer.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>95</volume>
            <issue>7</issue>
            <fpage>473</fpage>
            <page-range>473-6</page-range>
            <pub-id pub-id-type="pmid">24112491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutter</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>East</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cripps</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Docherty</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dolwani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Monahan</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Novelli</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Plumb</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Thomas-Gibson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tolan</surname>
                <given-names>DJM</given-names>
              </name>
              <name>
                <surname>Whyte</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonnington</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scope</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hibbert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marsh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moores</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines.</article-title>
            <source>Gut</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>201</fpage>
            <page-range>201-223</page-range>
            <pub-id pub-id-type="pmid">31776230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Perdue</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Henrikson</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Blasi</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</article-title>
            <source>JAMA</source>
            <year>2021</year>
            <month>May</month>
            <day>18</day>
            <volume>325</volume>
            <issue>19</issue>
            <fpage>1978</fpage>
            <page-range>1978-1998</page-range>
            <pub-id pub-id-type="pmid">34003220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Causada-Calo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bishay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Albashir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al Mazroui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Association Between Age and Complications After Outpatient Colonoscopy.</article-title>
            <source>JAMA Netw Open</source>
            <year>2020</year>
            <month>Jun</month>
            <day>01</day>
            <volume>3</volume>
            <issue>6</issue>
            <fpage>e208958</fpage>
            <pub-id pub-id-type="pmid">32584409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reumkens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van der Zander</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Winkens</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bogie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bakker</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Sanduleanu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Masclee</surname>
                <given-names>AAM</given-names>
              </name>
            </person-group>
            <article-title>Electrolyte disturbances after bowel preparation for colonoscopy: Systematic review and meta-analysis.</article-title>
            <source>Dig Endosc</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>913</fpage>
            <page-range>913-926</page-range>
            <pub-id pub-id-type="pmid">35037327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bernheim</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bagiella</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jandorf</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Itzkowitz</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Effect of Functional Status on the Quality of Bowel Preparation in Elderly Patients Undergoing Screening and Surveillance Colonoscopy.</article-title>
            <source>Gut Liver</source>
            <year>2016</year>
            <month>Jul</month>
            <day>15</day>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>569</fpage>
            <page-range>569-73</page-range>
            <pub-id pub-id-type="pmid">27021501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cairns</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Scholefield</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Steele</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Dunlop</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Eaden</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rutter</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Atkin</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Lucassen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fairclough</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Woodhouse</surname>
                <given-names>CR</given-names>
              </name>
              <collab>British Society of Gastroenterology</collab>
              <collab>Association of Coloproctology for Great Britain and Ireland</collab>
            </person-group>
            <article-title>Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).</article-title>
            <source>Gut</source>
            <year>2010</year>
            <month>May</month>
            <volume>59</volume>
            <issue>5</issue>
            <fpage>666</fpage>
            <page-range>666-89</page-range>
            <pub-id pub-id-type="pmid">20427401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scalise</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mantarro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pancrazi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Neri</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Computed tomography colonography for the practicing radiologist: A review of current recommendations on methodology and clinical indications.</article-title>
            <source>World J Radiol</source>
            <year>2016</year>
            <month>May</month>
            <day>28</day>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>472</fpage>
            <page-range>472-83</page-range>
            <pub-id pub-id-type="pmid">27247713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-161160.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koulaouzidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rondonotti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Giannakou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plevris</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic yield of small-bowel capsule endoscopy in patients with iron-deficiency anemia: a systematic review.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>76</volume>
            <issue>5</issue>
            <fpage>983</fpage>
            <page-range>983-92</page-range>
            <pub-id pub-id-type="pmid">23078923</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
